b-Endorphin and Reproduction: Evidence for Ovarian Participation

  • A. R. Genazzani
  • F. Petraglia
  • F. Mercantini
  • A. Monzani
  • G. D’Andrea
  • F. Facchinetti


Many studies have accumulated on the Proopiomelanocortin (POMC) family of peptides since they appear to be involved in various physiological processes. b-Endorphin (b-EP) in particular displays either neurotransmitter or hormonal actions, even though its targets remain to be established. The possible interactions of b-EP with reproductive processes could be operating at three different levels: the hypothalamus, the pituitary and the gonads.


Granulosa Cell Follicular Fluid Preovulatory Follicle Estradiol Benzoate Uterine Fluid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Genazzani AR, Facchinetti F, Pintor C, et al. Proopiocortin-related peptide plasma levels throughout prepuberty and puberty. J Clin Endo Metab 1983; 57: 56–61.CrossRefGoogle Scholar
  2. 2.
    Tilders FJH, Post M, Jackson S, Lowry PJ, Smelik PG. Beta-adrenergic stimulation of the release of ACTH- and LPH-related peptides from the pars intermedia of the rat pituitary gland. Acta Endocrinology 1981; 97: 343–351.Google Scholar
  3. 3.
    Sicuteri F. Is acute tolerance to 5-hydroxytryptamine opioid dependent? Its absence in migraine sufferers. Cephalalgia 1983; 3: 187–90.CrossRefGoogle Scholar
  4. 4.
    Petraglia F, Penalva A, Locatelli V, et al. Effect of gonadectomy and gonadal steroid replacement on pituitary and plasma β-endorphin levels in the rat. Clin Endocrinol 1982; 111: 1224–9.Google Scholar
  5. 5.
    Genazzani AR, Facchinetti F, Parrine D. β-Lipotrophin and β-endorphin plasma levels during pregnancy. Clin Endocrinol 1981; 14: 409–18.CrossRefGoogle Scholar
  6. 6.
    Facchinetti F, Centini G, Parrini D, et al. Opioid plasma levels during labour. Gynaecol Obstet Invest 1982; 13: 155–63.CrossRefGoogle Scholar
  7. 7.
    Genazzani AR, Facchinetti F, Ricci-Danero MG, et al. Beta-lipotropin and beta-endorphin in physiological and surgical menopause. J Endocrinol Invest 1981; 4: 375–78.Google Scholar
  8. 8.
    Melis GB, Paoletti AM, Gambacciani M, Mais V, Fioretti P. Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using naloxone. Neuroendocrinology 1984; 39: 60–3.CrossRefGoogle Scholar
  9. 9.
    Degli Uberti EC, Petraglia F, Trasforini G, et al. Effect of dermorphin on metyrapone-evoked release of acth, β-endorphin and β-lipotropin in man. J Endocrinol Invest 1985; 8: suppl 3.Google Scholar
  10. 10.
    Krieger DT, Martin JB. Brain peptides. New Engl J Med 1981; 304: 876–85.CrossRefGoogle Scholar
  11. 11.
    Specific nonopiate receptors for β-endorphin. Science 1979; 205: 1033–5.Google Scholar
  12. 12.
    Genazzani AR, Petraglia V, Facchinetti F. Increase of proopiomelanocortin-related peptides during subjective menopausal flushes. Am J Obstet Gynaecol 1984; 149: 775–9.Google Scholar
  13. 13.
    Vermes I, Mulder GH, Smelik PG, Tilders FJH. Differential control of β-endorphin β-lipotropin secretion from anterior and intermediate lobes of the rat pituitary gland in vitro. Life Sci 1980; 27: 1761.CrossRefGoogle Scholar
  14. 14.
    Abadia R, Boschat M, Opolon P. Endorphines et tube digestif. Ann Med Interne 1983; 134: 742–53.Google Scholar
  15. 15.
    Tson SD, Phillips D, Halmi N, et al. ACTH and β-endorphin-related peptides are present in multiple sites in the reproductive tract of the male rat. Endocrinology 1982; 110: 2204–6.CrossRefGoogle Scholar
  16. 16.
    Margioris AN, Liotta AS, Vaudry H, Wayne Bardin C, Krieger DT. Characterization of immunoreactive proopiomelanocortin-related peptides in rat testes. Endocrinology 1982; 113: 663.CrossRefGoogle Scholar
  17. 17.
    Cheng MC, Clements JA, Smit AI, Lolait SJ, Funder JW. N-Acetyl endorphin in rat spermatogonia and primary spermatocytes. J Clin Invest 1985; 75: 832.CrossRefGoogle Scholar
  18. 18.
    Sharp B, Pekary AE. β-Endorphin 61–91 and other β-endorphin-immunoreactive peptides in human semen. J Clin Endocrinol Metab 1981; 52: 586.CrossRefGoogle Scholar
  19. 19.
    Fabbri A, Gnessi L, Perricone R, et al. Human semen inhibits T rosette formation through an opiate mediated mechanism. J Clin Endocrinol Metab 1985; 60: 807–9.CrossRefGoogle Scholar
  20. 20.
    Lolait SJ, Autelitano DJ, Lim ATW, Smith AI, Hock Toh B, Funder JW. Ovarian immunoreactive β-endorphin and estrous cycle in the rat. Endocrinology 1985; 117: 161–8.CrossRefGoogle Scholar
  21. 21.
    Shaha C, Margioris A, Liotta AS, Krieger DT, Bardin CW. Demonstration of immunoreactive β-endorphin- and γ 3-melanocyte-stimulating hormone-related peptides in the ovaries of neonatal, cyclic, and pregnant mice. Endocrinology 1984; 115: 378–84.CrossRefGoogle Scholar
  22. 22.
    Chen C-LC, Chang C-C, Krieger DT, Bardin CW. Expression and regulation of proopiomelanocortin-like gene in the ovary and placenta: comparison with the testis. Endocrinology 1986; 118: 2382.Google Scholar
  23. 23.
    Petraglia F, Segre A, Facchinetti F, Campanini D, Ruspa M, Genazzani A. β-Endorphin and met-enkephalin in peritoneal and ovarian follicular fluids of fertile and postmenopausal women. Fertil Steril 1985; 44: 615–21.Google Scholar
  24. 24.
    Alleem FA, Omar RA, ElTabbakh GH. Immunoreactive β-endorphin in human ovaries. Fertil Steril 1986; 45: 507–11.Google Scholar
  25. 25.
    Davis JM, Lowy MT, Yim GKW, Lamb DR, Malven PV. Relationship between plasma concentrations of immunoreactive beta-endorphin and food intake in rats. Peptides 1983; 4: 79–83.CrossRefGoogle Scholar
  26. 26.
    Genazzani AR, Nappi G, Facchinetti F, et al. Central deficiency of β-endorphin in alcohol addicts. J Clin Endocrinol Metab 1982; 55: 583–6.CrossRefGoogle Scholar
  27. 27.
    Facchinetti F, Ruspa M, Turci A, et al. Met-enkephalin enhances follicle-stimulating hormone-dependent progesterone production from cultured granulosa cells. J Clin Endocrinol Metab 1986; 63: 1222–4.CrossRefGoogle Scholar
  28. 28.
    Kilpatrick DL, Howells RD, Noe M, Bailey LC, Udenfriend S. Expression of preproenkephalin-like mRNA and its peptide products in mammalian testis and ovary. Proc Natl Acad Sci USA 1985; 82: 7467–9.CrossRefGoogle Scholar
  29. 29.
    Spampinato S, Goldstein A. Immunoreactive dynorphin in rat tissues and plasma. Neuropeptides 1983; 3: 193–212.CrossRefGoogle Scholar
  30. 30.
    Petraglia F, Facchinetti F, M’Futa K, et al. Endogenous opioid peptides in uterine fluids. Fertil Steril 1986; 46: 247–51.Google Scholar
  31. 31.
    Wahlström T, Laatikainen T, Salminen K, Leppäluoto. Immunoreactive β-endorphin is demonstrable in the secretory but not in the proliferative endometrium. Life Sci 1985; 36: 987–90.CrossRefGoogle Scholar
  32. 32.
    Veith JL, Anderson J, Slade SA, Thompson P, Laugel GR, Getzlaf S. Plasma β-endorphin, pain thresholds and anxiety levels across the human menstrual cycle. Physiol Behav 1984; 32: 31–4.CrossRefGoogle Scholar
  33. 33.
    Petraglia F, Di Meo G, De Leo V, Nappi C, Facchinetti F, Genazzani AR. Plasma β-endorphin levels in anovulatory states: changes after treatment for the induction of ovulation. Fertil Steril 1986; 45: 185–90.Google Scholar
  34. 34.
    Chuong CJ, Coulam CB, Chih Kao P, Bergstrahl EJ, Go VLW. Neuropeptide levels in premenstrual syndrome. Fertil Steril 1985; 44: 760–65.Google Scholar
  35. 35.
    Fertil Steril 1987; in press.Google Scholar
  36. 36.
    Reid RL. Neuropeptides and PMS. Fertil Steril 1986; 46: 738–39.Google Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • A. R. Genazzani
    • 1
  • F. Petraglia
    • 1
  • F. Mercantini
    • 1
  • A. Monzani
    • 1
  • G. D’Andrea
    • 1
  • F. Facchinetti
    • 1
  1. 1.Dept. of Obstetrics and GynecologyUniversity of ModenaModenaItaly

Personalised recommendations